The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
TevaGastrim for Stem Cell Mobilization Sibling Donors
- Status
- COMPLETED
- Phase
- PHASE2
VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study Comparing Siltuximab Plus Best Supportive Care to Placebo Plus Best Supportive Care in Anemic Patients With International Prognostic Scoring System Low- or Intermediate-1-Risk Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
- Status
- TERMINATED
- Phase
- PHASE2
Administration of Donor T Cells With the Caspase-9 Suicide Gene
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Tolerability of HSC835 in Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Treatment of Patients With Myelodysplastic Syndrome or Acute Myelocytic Leukemia With an Impending Hematological Relapse With Azacitidine (Vidaza)
- Status
- COMPLETED
- Phase
- PHASE2
PRO#0118: Decitabine Plus Mini Flu-Bu
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Study With Oral Panobinostat Maintenance Therapy Following Allogeneic Stem Cell Transplantation in Patients With High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
5-azacytidine Treatment Versus 5-azacytidine Followed by Allogeneic Stem Cell Transplantation in Elderly Patients With Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients
- Status
- COMPLETED
- Phase
- PHASE1
Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1
NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases
- Status
- COMPLETED
- Phase
- PHASE2